EUCTR2005-000755-15-GB进行中（未招募）不适用
Perhexiline therapy in patients with Hypertrophic Cardiomyopathy
niversity Hospital of Birmingham Foundation Trust0 个研究点目标入组 50 人开始时间: 2005年5月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Symptomatic non-obstructive hypertrophic cardiomyopathy patients with less than 70% of predicted peak Vo2 and in sinus rhythm
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Abnormal liver function test, Pre-existing peripheral neuropathy, Concomitant use of amiodarone and women of childbearing potential .
研究者
相似试验
已完成
2 期
Perhexiline Therapy in Patients With Hypertrophic CardiomyopathyHypertrophic CardiomyopathyNCT00500552University Hospital Birmingham44
进行中（未招募）
1 期
To look in to the breathlessness caused by HeartHeart failure with preserved left ventricular ejection fractionMedDRA version: 14.1 Level: HLGT Classification code 10019280 Term: Heart failures System Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1 Level: HLT Classification code 10019283 Term: Heart failure signs and symptoms System Organ Class: 10007541 - Cardiac disordersMedDRA version: 14.1 Level: HLT Classification code 10019281 Term: Heart failures NEC System Organ Class: 10007541 - Cardiac disordersEUCTR2006-001109-28-GBniversity of Aberdeen72
已完成
3 期
Evaluation of the efficacy of Pentoxiphyllin in hospitalized diabetic patients with covid19covid 19.U09Post-COVIDIRCT20230523058271N1Yazd University of Medical Sciences50
进行中（未招募）
不适用
SHCMEUCTR2011-004507-20-DEMenarini International Operations Luxembourg S.A.100
已完成
不适用
Treatment of hyperphenylalaninemia with Sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) and its influence on the amino acids and fatty acids patterns from childhood to adulthood (Tratamiento de la hiperfenilalaninemia con dihidrocloruro de Sapropterina [tetrahidrobiopterina, 6r-bh4] y su influencia en el patrón de aminoácidos y ácidos grasos desde la infancia hasta la edad adulta)ISRCTN77098312Aragon Institute of Health Sciences [Instituto Aragonés de Ciencias de la Salud] (Spain)30